Catalent (CTLT) Stock Forecast, Price Target & Predictions
CTLT Stock Forecast
Catalent stock forecast is as follows: an average price target of $76.40 (represents a 27.21% upside from CTLT’s last price of $60.06) and a rating consensus of 'Hold', based on 13 wall street analysts offering a 1-year stock forecast.
CTLT Price Target
CTLT Analyst Ratings
Catalent Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 24, 2024 | Eric Coldwell | Robert W. Baird | $63.50 | $59.75 | 6.28% | 5.73% |
May 20, 2024 | Jacob Johnson | Stephens | $63.50 | $55.37 | 14.68% | 5.73% |
May 19, 2023 | Sean Dodge | RBC Capital | $41.00 | $32.14 | 27.57% | -31.73% |
May 19, 2023 | Evan Stover | Robert W. Baird | $53.00 | $32.14 | 64.90% | -11.75% |
Feb 08, 2023 | - | Barclays | $82.00 | $71.58 | 14.56% | 36.53% |
Dec 08, 2022 | Evan Stover | Robert W. Baird | $75.00 | $44.98 | 66.76% | 24.88% |
Aug 30, 2022 | Luke Sergott | Barclays | $125.00 | $92.28 | 35.46% | 108.13% |
May 04, 2022 | - | Morgan Stanley | $132.00 | $100.94 | 30.78% | 119.78% |
Catalent Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 1 | 2 |
Avg Price Target | $63.50 | $63.50 | $63.50 |
Last Closing Price | $60.06 | $60.06 | $60.06 |
Upside/Downside | 5.73% | 5.73% | 5.73% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 28, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Jun 21, 2024 | William Blair | Market Perform | Market Perform | Hold |
May 20, 2024 | Stephens | Equal-Weight | Equal-Weight | Hold |
Apr 04, 2024 | UBS | Sector Perform | Sector Perform | Hold |
Feb 20, 2024 | UBS | Sector Perform | Sector Perform | Hold |
Feb 06, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
Sep 05, 2023 | Bernstein | - | Outperform | Upgrade |
Sep 05, 2023 | Susquehanna | - | Positive | Upgrade |
Sep 05, 2023 | UBS | - | Underperform | Downgrade |
Sep 05, 2023 | Goldman Sachs | - | Buy | Upgrade |
Catalent Financial Forecast
Catalent Revenue Forecast
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | $1.03B | $982.00M | $1.07B | $1.04B | $1.15B | $1.02B | $1.31B | $1.27B | $1.22B | $1.02B | $1.19B | $1.05B | $910.80M | $845.70M | $947.60M | $760.60M | $721.40M | $664.70M | $725.70M | $617.50M |
Avg Forecast | $1.42B | $1.25B | $1.23B | $1.14B | $1.35B | $1.17B | $1.13B | $1.06B | $1.22B | $1.12B | $1.01B | $934.96M | $1.05B | $952.66M | $1.12B | $1.08B | $1.33B | $1.22B | $1.15B | $1.03B | $1.14B | $989.11M | $892.45M | $811.37M | $895.51M | $692.53M | $700.81M | $636.72M | $721.03M | $644.07M |
High Forecast | $1.42B | $1.25B | $1.23B | $1.14B | $1.35B | $1.17B | $1.13B | $1.12B | $1.22B | $1.12B | $1.05B | $975.44M | $1.05B | $952.66M | $1.12B | $1.08B | $1.33B | $1.22B | $1.15B | $1.03B | $1.14B | $989.11M | $892.45M | $811.37M | $895.51M | $692.53M | $700.81M | $636.72M | $721.03M | $644.07M |
Low Forecast | $1.42B | $1.25B | $1.23B | $1.14B | $1.35B | $1.17B | $1.13B | $1.02B | $1.22B | $1.12B | $988.42M | $834.33M | $1.05B | $952.66M | $1.12B | $1.08B | $1.33B | $1.22B | $1.15B | $1.03B | $1.14B | $989.11M | $892.45M | $811.37M | $895.51M | $692.53M | $700.81M | $636.72M | $721.03M | $644.07M |
# Analysts | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.05% | 1.01% | 1.09% | 1.02% | 0.95% | 0.99% | 1.04% | 1.06% | 0.99% | 1.04% | 1.06% | 1.02% | 1.04% | 1.06% | 1.10% | 1.03% | 1.04% | 1.01% | 0.96% |
Catalent EBITDA Forecast
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | $-111.00M | $-48.00M | $-96.00M | $-235.00M | $239.00M | $159.00M | $243.00M | $312.00M | $245.00M | $210.00M | $326.40M | $419.90M | $205.90M | $161.80M | $265.90M | $128.90M | $155.30M | $90.10M | $160.00M | $135.40M |
Avg Forecast | $170.91M | $150.19M | $148.31M | $137.83M | $162.32M | $141.45M | $136.30M | $127.66M | $147.63M | $333.03M | $121.63M | $112.77M | $127.03M | $302.76M | $135.59M | $129.98M | $160.05M | $275.23M | $138.69M | $124.80M | $137.44M | $374.51M | $107.64M | $97.86M | $108.01M | $123.53M | $84.53M | $76.80M | $86.97M | $126.57M |
High Forecast | $170.91M | $150.19M | $148.31M | $137.83M | $162.32M | $141.45M | $136.30M | $134.75M | $147.65M | $399.64M | $126.45M | $117.65M | $127.03M | $363.31M | $135.59M | $129.98M | $160.05M | $330.28M | $138.69M | $124.80M | $137.44M | $449.41M | $107.64M | $97.86M | $108.01M | $148.23M | $84.53M | $76.80M | $86.97M | $151.88M |
Low Forecast | $170.91M | $150.19M | $148.31M | $137.83M | $162.32M | $141.45M | $136.30M | $122.93M | $147.61M | $266.43M | $119.22M | $100.63M | $127.03M | $242.21M | $135.59M | $129.98M | $160.05M | $220.19M | $138.69M | $124.80M | $137.44M | $299.60M | $107.64M | $97.86M | $108.01M | $98.82M | $84.53M | $76.80M | $86.97M | $101.26M |
Surprise % | - | - | - | - | - | - | - | - | - | - | -0.91% | -0.43% | -0.76% | -0.78% | 1.76% | 1.22% | 1.52% | 1.13% | 1.77% | 1.68% | 2.37% | 1.12% | 1.91% | 1.65% | 2.46% | 1.04% | 1.84% | 1.17% | 1.84% | 1.07% |
Catalent Net Income Forecast
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | $-204.00M | $-715.00M | $-86.00M | $-227.00M | $81.00M | - | $188.00M | $141.00M | $97.00M | $93.00M | $182.40M | $231.80M | $88.40M | $82.40M | $154.20M | $20.90M | $45.50M | $100.00K | $65.70M | $31.70M |
Avg Forecast | $137.18M | $66.53M | $65.97M | $37.53M | $113.25M | $50.73M | $35.11M | $8.27M | $85.41M | $152.46M | $-3.88M | $-24.98M | $19.97M | $138.60M | $125.84M | $102.15M | $210.76M | $126.00M | $152.67M | $118.95M | $201.18M | $206.74M | $101.38M | $67.28M | $144.41M | $20.03M | $81.59M | $44.21M | $118.01M | $29.63M |
High Forecast | $137.18M | $66.53M | $65.97M | $37.53M | $113.25M | $50.73M | $35.11M | $14.29M | $85.44M | $182.95M | $1.29M | $-9.61M | $19.97M | $166.32M | $125.84M | $102.15M | $211.03M | $151.20M | $152.67M | $118.95M | $209.24M | $248.09M | $101.38M | $67.28M | $144.41M | $24.03M | $81.59M | $44.21M | $118.01M | $35.56M |
Low Forecast | $137.18M | $66.53M | $65.97M | $37.53M | $113.25M | $50.73M | $35.11M | $751.85K | $85.39M | $121.97M | $-10.36M | $-38.43M | $19.97M | $110.88M | $125.84M | $102.15M | $210.49M | $100.80M | $152.67M | $118.95M | $193.12M | $165.39M | $101.38M | $67.28M | $144.41M | $16.02M | $81.59M | $44.21M | $118.01M | $23.71M |
Surprise % | - | - | - | - | - | - | - | - | - | - | 52.51% | 28.62% | -4.31% | -1.64% | 0.64% | - | 0.89% | 1.12% | 0.64% | 0.78% | 0.91% | 1.12% | 0.87% | 1.22% | 1.07% | 1.04% | 0.56% | 0.00% | 0.56% | 1.07% |
Catalent SG&A Forecast
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | $239.00M | $215.00M | $219.00M | $190.00M | $226.00M | $196.00M | $226.00M | $207.00M | $228.00M | $183.00M | $184.10M | $172.70M | $165.50M | $164.70M | $158.00M | $136.10M | $141.00M | $142.80M | $143.40M | $129.90M |
Avg Forecast | $256.63M | $225.53M | $222.71M | $206.97M | $243.75M | $212.41M | $204.68M | $191.69M | $221.68M | $223.82M | $182.65M | $169.33M | $190.74M | $203.48M | $203.60M | $195.18M | $240.33M | $184.98M | $208.25M | $187.39M | $206.37M | $154.03M | $161.63M | $146.95M | $162.19M | $130.43M | $126.93M | $115.32M | $130.59M | $121.43M |
High Forecast | $256.63M | $225.53M | $222.71M | $206.97M | $243.75M | $212.41M | $204.68M | $202.34M | $221.71M | $268.59M | $189.88M | $176.66M | $190.74M | $244.17M | $203.60M | $195.18M | $240.33M | $221.97M | $208.25M | $187.39M | $206.37M | $184.84M | $161.63M | $146.95M | $162.19M | $156.51M | $126.93M | $115.32M | $130.59M | $145.71M |
Low Forecast | $256.63M | $225.53M | $222.71M | $206.97M | $243.75M | $212.41M | $204.68M | $184.59M | $221.66M | $179.06M | $179.02M | $151.11M | $190.74M | $162.78M | $203.60M | $195.18M | $240.33M | $147.98M | $208.25M | $187.39M | $206.37M | $123.22M | $161.63M | $146.95M | $162.19M | $104.34M | $126.93M | $115.32M | $130.59M | $97.14M |
Surprise % | - | - | - | - | - | - | - | - | - | - | 1.31% | 1.27% | 1.15% | 0.93% | 1.11% | 1.00% | 0.94% | 1.12% | 1.09% | 0.98% | 0.89% | 1.12% | 1.02% | 1.12% | 0.97% | 1.04% | 1.11% | 1.24% | 1.10% | 1.07% |
Catalent EPS Forecast
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | $-1.12 | $-3.95 | $-0.48 | $-1.25 | $0.45 | - | $1.04 | $0.78 | $0.55 | $0.49 | $0.98 | $1.27 | $0.46 | $0.42 | $0.86 | $0.08 | $0.23 | - | $0.45 | $0.22 |
Avg Forecast | $0.75 | $0.36 | $0.36 | $0.21 | $0.62 | $0.28 | $0.19 | $0.05 | $0.47 | $0.22 | $-0.02 | $-0.14 | $0.11 | $-0.07 | $0.69 | $0.56 | $1.15 | $0.94 | $0.83 | $0.65 | $1.10 | $0.74 | $0.55 | $0.37 | $0.79 | $0.48 | $0.45 | $0.24 | $0.64 | $0.46 |
High Forecast | $0.75 | $0.36 | $0.36 | $0.21 | $0.62 | $0.28 | $0.19 | $0.08 | $0.47 | $0.22 | $0.01 | $-0.05 | $0.11 | $-0.07 | $0.69 | $0.56 | $1.15 | $0.94 | $0.83 | $0.65 | $1.14 | $0.74 | $0.55 | $0.37 | $0.79 | $0.48 | $0.45 | $0.24 | $0.64 | $0.46 |
Low Forecast | $0.75 | $0.36 | $0.36 | $0.21 | $0.62 | $0.28 | $0.19 | - | $0.47 | $0.22 | $-0.06 | $-0.21 | $0.11 | $-0.07 | $0.69 | $0.56 | $1.15 | $0.94 | $0.83 | $0.65 | $1.06 | $0.74 | $0.55 | $0.37 | $0.79 | $0.48 | $0.45 | $0.24 | $0.64 | $0.46 |
Surprise % | - | - | - | - | - | - | - | - | - | - | 52.76% | 28.94% | -4.40% | 17.76% | 0.65% | - | 0.90% | 0.83% | 0.66% | 0.75% | 0.89% | 1.72% | 0.83% | 1.14% | 1.09% | 0.17% | 0.52% | 0.00% | 0.70% | 0.48% |
Catalent Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
CRL | Charles River Laboratories | $197.78 | $303.60 | 53.50% | Buy |
BIO | Bio-Rad Laboratories | $343.98 | $482.50 | 40.27% | Buy |
TFX | Teleflex | $234.14 | $304.82 | 30.19% | Buy |
CTLT | Catalent | $60.09 | $76.40 | 27.14% | Hold |
WST | West Pharmaceutical Services | $288.66 | $345.33 | 19.63% | Buy |
IQV | IQVIA | $233.89 | $270.35 | 15.59% | Buy |
CTLT Forecast FAQ
Is Catalent a good buy?
No, according to 13 Wall Street analysts, Catalent (CTLT) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 38.46% of CTLT's total ratings.
What is CTLT's price target?
Catalent (CTLT) average price target is $76.4 with a range of $41 to $132, implying a 27.21% from its last price of $60.06. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Catalent stock go up soon?
According to Wall Street analysts' prediction for CTLT stock, the company can go up by 27.21% (from the last price of $60.06 to the average price target of $76.4), up by 119.78% based on the highest stock price target, and down by -31.73% based on the lowest stock price target.
Can Catalent stock reach $90?
CTLT's highest twelve months analyst stock price target of $132 supports the claim that Catalent can reach $90 in the near future.
What is Catalent's current price target trend?
1 Wall Street analyst forecast a $63.5 price target for Catalent (CTLT) this month, up 5.73% from its last price of $60.06. Compared to the last 3 and 12 months, the average price target increased by 5.73% and increased by 5.73%, respectively.
What are Catalent's analysts' financial forecasts?
Catalent's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $4.71B (high $4.77B, low $4.67B), average EBITDA is $567.74M (high $574.83M, low $563.01M), average net income is $207.36M (high $213.38M, low $199.84M), average SG&A $852.52M (high $863.17M, low $845.42M), and average EPS is $1.13 (high $1.17, low $1.09). CTLT's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $5.03B (high $5.03B, low $5.03B), average EBITDA is $607.24M (high $607.24M, low $607.24M), average net income is $307.21M (high $307.21M, low $307.21M), average SG&A $911.84M (high $911.84M, low $911.84M), and average EPS is $1.68 (high $1.68, low $1.68).
Did the CTLT's actual financial results beat the analysts' financial forecasts?
Based on Catalent's last annual report (Jun 2023), the company's revenue was $4.28B, beating the average analysts forecast of $4.21B by 1.62%. Apple's EBITDA was $79M, missing the average prediction of $695.35M by -88.64%. The company's net income was $-232M, missing the average estimation of $386.56M by -160.02%. Apple's SG&A was $831M, beating the average forecast of $793M by 4.79%. Lastly, the company's EPS was $-1.28, missing the average prediction of $1.28 by -199.64%. In terms of the last quarterly report (Dec 2023), Catalent's revenue was $1.03B, beating the average analysts' forecast of $1.01B by 2.33%. The company's EBITDA was $-111M, missing the average prediction of $121.63M by -191.26%. Catalent's net income was $-204M, beating the average estimation of $-3.885M by 5151.09%. The company's SG&A was $239M, beating the average forecast of $182.65M by 30.85%. Lastly, the company's EPS was $-1.12, beating the average prediction of $-0.0212 by 5175.80%